The effects of zinc supplementation in the treatment of patients with brucellosis
Phase 3
- Conditions
- Brucellosis.Brucellosis
- Registration Number
- IRCT20170513033941N70
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients diagnosed with brucellosis
Individuals aged 18-80 years
Exclusion Criteria
Taking any antioxidant and/or anti-inflammatory supplements within 3 months prior to the enrollment.
Patients diagnosed with acquired immunosuppressive disease
Patients who are receiving any immunosuppressive drugs.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum hs-CRP levels. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa.
- Secondary Outcome Measures
Name Time Method